SCHEMBL1699146

SCHEMBL1699146

O=C1Cn2c(nc3ccccc32)N1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
IRAK4 Q9NWZ3 4/20 0.44
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 2/20 0.42
PKM P14618 2/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
DDB1 Q16531 2/20 0.40
CRBN Q96SW2 2/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8729916 0.85 TSHR (0.46) TSHRIRAK4KDM4EHSD17B10PKM
SCHEMBL32688313 0.83 CRBN (0.44) TSHRKDM4EHSD17B10DDB1CRBN
SCHEMBL1713613 0.83 CRBN (0.44) TSHRKDM4EHSD17B10DDB1CRBN
SCHEMBL19807935 0.78 ALPI (0.40) IRAK4KDM4EHSD17B10PKMRAB9A
SCHEMBL5142126 0.73 ALDH1A1 (0.47) TSHRKDM4EHSD17B10RAB9ASMN1; SMN2
SCHEMBL1713450 0.73 TSHR (0.42) TSHRIRAK4KDM4ESMN1; SMN2DDB1
SCHEMBL13893346 0.70 POLB (0.49) TSHRTP53SMN1; SMN2ALDH1A1MEN1
SCHEMBL8797169 0.69 ALPI (0.41) TSHRKDM4ESMN1; SMN2DDB1CRBN
SCHEMBL14974497 0.68 KDM4E (0.41) TSHRKDM4EHSD17B10PKMNPC1
SCHEMBL31249024 0.68 KDM4E (0.61) TSHRKDM4EHSD17B10PKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2991990-B1 NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2017-02-01 EP disclosed
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed